Vivos Therapeutics Inc. (VVOS): Price and Financial Metrics

Vivos Therapeutics Inc. (VVOS): $4.69

0.04 (+0.86%)

POWR Rating

Component Grades













VVOS Stock Price Chart Interactive Chart >

Price chart for VVOS

VVOS Price/Volume Stats

Current price $4.69 52-week high $14.41
Prev. close $4.65 52-week low $2.61
Day low $4.60 Volume 703,600
Day high $4.96 Avg. volume 1,324,664
50-day MA $4.14 Dividend yield N/A
200-day MA $0.00 Market Cap 106.99M

Vivos Therapeutics Inc. (VVOS) Company Bio

Vivos Therapeutics, Inc., a medical technology company, engages in the development and commercialization of technology solutions for patients with sleep disordered breathing (SDB) comprising mild-to-moderate obstructive sleep apnea (OSA). The company's solutions cover proprietary alternatives for treating mild-to-moderate OSA; craniofacial and anatomical anomalies that are associated with mild-to-moderate OSA. Its treatment for OSA involves specially designed and customized oral appliances and treatment protocols. The company, through its Vivos Integrated Healthcare Network, provides access to healthcare providers for delivering care for patients suffering from sleep disordered breathing, including mild-to-moderate OSA. Vivos Therapeutics, Inc. also licenses its intellectual property to third-party manufacturers, which fabricate appliance devices for healthcare professionals. It caters to general dentists, medical doctors, myofunctional therapists, chiropractors, healthcare providers, and patients in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2007 and is based in Highlands Ranch, Colorado.

VVOS Latest News Stream

Event/Time News Detail
Loading, please wait...

VVOS Latest Social Stream

Loading social stream, please wait...

View Full VVOS Social Stream

Latest VVOS News From Around the Web

Below are the latest news stories about Vivos Therapeutics Inc that investors may wish to consider to help them evaluate VVOS as an investment opportunity.

Vivos Therapeutics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference

Vivos management to present at 7:00 am EDT on September 13, 2021 HIGHLANDS RANCH, Colo., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (OSA) and snoring, today announced that Kirk Huntsman, Chief Executive Officer, will be presenting at the H.C. Wainwright 23rd Annual Global Investment Confe

Yahoo | September 8, 2021

Implied Volatility Surging for Vivos (VVOS) Stock Options

Investors need to pay close attention to Vivos (VVOS) stock based on the movements in the options market lately.

Yahoo | August 26, 2021

Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep Apnea Diagnosis and Treatment

HIGHLANDS RANCH, Colo., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild to moderate obstructive sleep apnea (OSA), today announced a new cooperative relationship with Empower Sleep, a San Bernardino, Calif.-based company empowering patients with affordable,

Yahoo | August 26, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning, investor!

William White on InvestorPlace | August 24, 2021

Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates

Following the market opening Tuesday, the Dow traded up 0.11% to 35,374.12 while the NASDAQ rose 0.43% to 15,006.17. The S&P also rose, gaining 0.22% to 4,489.23. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 37,941,620 cases with around 629,560 deaths. India confirmed a total of at least 32,474,770 cases and 435,110 deaths, while Brazil reported over 20,583,990 COVID-19 cases with 574,840 deaths. In total, there were at least 212,639,390 case

Yahoo | August 24, 2021

Read More 'VVOS' Stories Here

VVOS Price Returns

1-mo 22.14%
3-mo -7.31%
6-mo -33.00%
1-year N/A
3-year N/A
5-year N/A
YTD -20.64%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6776 seconds.